Vertex Pharmaceuticals
VRTX
#154
Rank
A$196.91 B
Marketcap
A$776.65
Share price
-1.08%
Change (1 day)
19.72%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): A$22.86

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$23.63. In 2025 the company made an earnings per share (EPS) of A$23.33 an increase over its 2024 EPS that were of A-$3.11.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$22.86-2%
2025A$23.33-850.97%
2024A-$3.11-114.67%
2023A$21.178.17%
2022A$19.5742.64%
2021A$13.72-12.67%
2020A$15.71128.01%
2019A$6.89-44.54%
2018A$12.43670.09%
2017A$1.61-327.66%
2016A-$0.71-79.65%
2015A-$3.48-26.43%
2014A-$4.7453.92%
2013A-$3.08316.33%
2012A-$0.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07-57.37%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.82-62.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.67-119.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.50-93.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.82-71.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A-$3.63-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA